Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/2/2025

Basophilic Stippling Diagnosis and Management

Definition and Clinical Significance

  • Basophilic stippling refers to the presence of coarse, dark blue granules scattered throughout red blood cells on peripheral blood smears, representing aggregated ribosomes that become visible with Romanowsky stains like May-Grünwald-Giemsa, as defined by the American Society of Hematology 1
  • Basophilic stippling represents a dysplastic erythroid feature in Myelodysplastic Syndromes (MDS), found alongside other dysplastic changes including anisocytosis and poikilocytosis, according to the International Working Group for MDS 1

Diagnostic Approach

  • When basophilic stippling is identified, assess clinical context and complete blood count with differential, looking for cytopenias suggesting MDS, as recommended by the American College of Pathology 1, 2
  • Examine peripheral blood smear for additional dysplastic features, including Pseudo-Pelger-Huët cells, hypogranulation/degranulation of granulocytes, giant platelets, and platelet anisocytosis, as suggested by the European Hematology Association 1
  • If dysplastic features are present or cytopenias exist without clear etiology, perform bone marrow aspiration and biopsy with iron staining, and cytogenetic analysis, as mandated by the World Health Organization 1

Management

  • Risk stratification using cytogenetics and molecular markers is essential for managing MDS, with supportive care, disease-modifying therapy, and transplantation based on risk category, as recommended by the National Comprehensive Cancer Network 1
  • The American Society of Hematology recommends supportive care with transfusions for cytopenias, and disease-modifying therapy based on risk category for MDS patients with basophilic stippling 1